Farooq Phiriyasart

Real-world effectiveness of maternal genetically inactivated acellular pertussis vaccination in protecting infants under three months of age: a case-control study using concurrent community-based and test-negative controls.

Maternal aPgen vaccination during pregnancy was highly likely to provide robust VE against symptomatic-PCR confirmed pertussis in infants during the first three months of life, and support the maternal pertussis vaccination with recombinant aP vaccines as effective strategy in Thailand and could be considered for other...